Prof David Hunt retweeted
Research by @HuntLabEdin & @DrMcglasson (UK DRI at Edinburgh) sheds light on the mechanisms behind RVCL-S, a rare genetic disorder that affects small blood vessels.
The study identifies an important therapeutic target👉 buff.ly/QwmdOV5
Prof David Hunt retweeted
🧠Calling neuroimmunology/MS clinicians, scientists, ECRs & healthcare professionals.
Neuroimmunology & MS 2025 will be held in Edinburgh on 11 - 12 March 2025 & features the Belinda Weller Distinguished Lecture.
Info: edin.ac/3NVD9UN
@ABNTrainees @DCNNeuro @HuntLabEdin
Prof David Hunt retweeted
There’s a wide range of topics at this year’s Neuroimmunology & MS 2025 meeting. To register, submit your abstract & to view the list of topics visit: edin.ac/3NVD9UN
pls share @EdinUniNeuro @HuntLabEdin @DCNNeuro @foley_p_neuro
@EdinUniImaging
#neuroimmunology_MS_25
Prof David Hunt retweeted
⭐️The UK DRI exists to transform the lives of people affected by or at risk of neurodegenerative conditions.⭐️
Our vision is ‘healthy brain🧠ageing for all’.
Our research will transform lives.
We are the UK DRI.
@The_MRC @alzheimerssoc @AlzResearchUK @lifearc1 @TheBHF @NIHRresearch
Prof David Hunt retweeted
🗓️ Neuroimmunology & MS 2025🗓️
Registration & abstract submission is now OPEN!
We have an excellent line up of topics & guest speakers covering all things neuroimmunology & MS.
More info 👉 edin.ac/3NVD9UN #neuroimmunology_MS_25 #ExtraordinaryEdinburgh
Pls reTweet
Prof David Hunt retweeted
📣Excited to share our latest study showing:
🎯IFN-α2 levels differentiate between T2T states in cSLE
🎯Elevated IFN-α2 predictive of flare when in target
⁉️potential for biomarker-driven cSLE T2T trials
🔗 doi.org/10.1093/rheumatology…
@CrowYanick @HuntLabEdin @ValentinaNatol1
Prof David Hunt retweeted
Maybe the best poster at #ECTRIMS2024 ? EBV latent viral load predicting disease activity in MS
Lots of interest @kearnsneuro @HuntLabEdin @foley_p_neuro @AnneRowlClinic
Prof David Hunt retweeted
'Unweaving type I interferons in age-related neuroinflammation'
@TrendsNeuro Spotlight by David Hunt & Markus Hofer
cell.com/trends/neuroscience…
discussing Roy et al. 2024, @MolNeuro, @WeiCao_PhD group
molecularneurodegeneration.b…
Prof David Hunt retweeted
Introducing, Oxford Laboratory for Neuroimmunology and Immunopsychiatry (OLNI)! We are a group of clinicians and scientists who want to understand how inflammation affects the brain.
@Annapoorna2024 @tomj_14 @handunnetthi @babakneuro @Greg__Holt @LaurissaJoy
Watch this space!
Prof David Hunt retweeted
Aicardi-Goutieres syndrome is a rare disease that can trigger #dementia in children.
Previous Emerging Leaders Prize winner @HuntLabEdin recently co-led a study, funded in part by @MedResFdn, that could lead to new treatments for this condition.
bit.ly/3LQdjjM @UKDRI
Prof David Hunt retweeted
Promising pathway discovered to treat rare childhood brain disease
A study co-led by @Sydney_Uni + @CPC_usyd Assoc Prof Markus Hofer + Prof @HuntLabEdin reveals fresh insight into the mechanisms underlying a rare disease that can cause childhood dementia Aicardi-Goutières syndrome.
The research, featured on the front cover of the journal Immunity @CellPressNews, could lead to urgently needed new therapeutic targets for the condition.
Read the story 🧠 ➡️ bit.ly/4fzync0
Prof David Hunt retweeted
Delighted that our work on interferon-alpha driven brain disease has made the front cover of @ImmunityCP after many years of work with brilliant collaborators in Australia, France and US. Short summary of paper to follow.
This month's beautiful cover depicts work from Hofer, @HuntLabEdin, Viengkhou &co showing that in Aicardi-Goutières syndrome, neurotoxic IFNα originates in the CNS & mediates disease primarily through its effects on the cerebral microvasculature. Image by Ben Gartland, Grant Foster, and Holly Philip.
cell.com/immunity/issue?pii=…
Prof David Hunt retweeted
This month's beautiful cover depicts work from Hofer, @HuntLabEdin, Viengkhou &co showing that in Aicardi-Goutières syndrome, neurotoxic IFNα originates in the CNS & mediates disease primarily through its effects on the cerebral microvasculature. Image by Ben Gartland, Grant Foster, and Holly Philip.
cell.com/immunity/issue?pii=…
Prof David Hunt retweeted
The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathies dlvr.it/T9W3vX
Prof David Hunt retweeted
Important research led by @HuntLabEdin reveals fresh insight into the mechanisms underlying a rare disease that can cause childhood dementia🧠
The study could lead to urgently needed new therapeutic targets for Aicardi-Goutières syndrome👉buff.ly/3KGZrI2
Prof David Hunt retweeted
A myelinic channel system for organelle transport to the glial-axonal junction biorxiv.org/content/10.1101/…
Thanks to all co-authors on and off X @KlausNave @werner_hauke @DrChapple @tabifromengland @Lina_Komarek @ColinPhD @RebeccaSmithPhD @MacpEuan
Prof David Hunt retweeted
also see accompanying blog post by lead author Emma Copland communities.springernature.c…
NEW PAPER - safety of COVID-19 vaccination in 5 million children. @UniofOxford @OxPrimaryCare @NIHRresearch
nature.com/articles/s41467-0…
Prof David Hunt retweeted
NEW PAPER - safety of COVID-19 vaccination in 5 million children. @UniofOxford @OxPrimaryCare @NIHRresearch
nature.com/articles/s41467-0…
Prof David Hunt retweeted
(1/6🧵) 📢We're recruiting! Join our world-class environment integrating #NHS care & #EdinburghUni brain disease research.
Positions for Aug 2024.
Deadline Mar 29th.
1) 1yr Clinical Fellow
2) 3yr Clinical PhD Scholar
3) 1yr Graduate Research Practitioner #graduatejob
Prof David Hunt retweeted
Before we sign off for the holidays we wanted to share this message to all #FutureMS research participants, from the team here at the Anne Rowling Clinic & at our sites across Scotland. We are so grateful for your involvement! 🙏
@dr_niall @HuntLabEdin @peterfoley10 @kearnsneuro























